Cellectis Price To Sales Ratio vs Capex To Operating Cash Flow Analysis

CLLS Stock

USD 2.13 0.01 0.47%

Cellectis financial indicator trend analysis is way more than just evaluating Cellectis SA prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cellectis SA is a good investment. Please check the relationship between Cellectis Price To Sales Ratio and its Capex To Operating Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Price To Sales Ratio vs Capex To Operating Cash Flow

Price To Sales Ratio vs Capex To Operating Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cellectis SA Price To Sales Ratio account and Capex To Operating Cash Flow. At this time, the significance of the direction appears to have no relationship.

The correlation between Cellectis' Price To Sales Ratio and Capex To Operating Cash Flow is 0.04. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Operating Cash Flow in the same time period over historical financial statements of Cellectis SA, assuming nothing else is changed. The correlation between historical values of Cellectis' Price To Sales Ratio and Capex To Operating Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Cellectis SA are associated (or correlated) with its Capex To Operating Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Operating Cash Flow has no effect on the direction of Price To Sales Ratio i.e., Cellectis' Price To Sales Ratio and Capex To Operating Cash Flow go up and down completely randomly.

Correlation Coefficient

0.04

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Cellectis SA stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Cellectis sales, a figure that is much harder to manipulate than other Cellectis SA multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Operating Cash Flow

Most indicators from Cellectis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cellectis SA current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

At this time, Cellectis' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 389.6 K in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 50 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	5.3M	3.8M	6.4M	6.7M
Depreciation And Amortization	16.6M	18.4M	18.5M	19.4M

Interest Expense Depreciation And Amortization

Cellectis fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Short Long Term Debt Total	Accounts Payable	Intangible Assets	Current Deferred Revenue	Retained Earnings
Total Assets		0.46	0.27	0.89	0.48	-0.72	0.89	0.34	0.34	0.91	0.33	-0.5	0.79	0.31	0.0	0.64	0.92	0.34	0.4	0.94	-0.5	0.3	0.22	-0.46	0.12	-0.79
Other Current Liab	0.46		0.24	0.27	0.7	-0.06	0.23	0.53	0.06	0.24	0.25	-0.63	0.65	0.48	0.62	0.76	0.63	0.42	0.59	0.29	-0.63	0.51	0.08	-0.64	-0.02	-0.66
Total Current Liabilities	0.27	0.24		-0.07	0.37	0.04	0.15	0.13	-0.01	0.23	0.32	-0.4	0.54	0.46	-0.04	0.05	0.21	0.85	0.64	0.24	-0.39	0.43	0.02	-0.36	0.93	-0.29
Total Stockholder Equity	0.89	0.27	-0.07		0.12	-0.92	0.95	0.03	0.32	0.93	0.13	-0.39	0.52	-0.1	-0.08	0.51	0.78	-0.1	-0.01	0.94	-0.4	-0.11	-0.01	-0.39	-0.11	-0.55
Property Plant And Equipment Net	0.48	0.7	0.37	0.12		0.23	0.07	0.92	0.1	0.1	0.54	-0.33	0.68	0.9	0.32	0.6	0.64	0.74	0.93	0.16	-0.33	0.91	0.55	-0.31	0.05	-0.85
Net Debt	-0.72	-0.06	0.04	-0.92	0.23		-0.94	0.36	-0.31	-0.92	0.07	0.4	-0.33	0.4	0.22	-0.26	-0.56	0.26	0.29	-0.91	0.41	0.42	0.28	0.4	-0.05	0.24
Cash	0.89	0.23	0.15	0.95	0.07	-0.94		-0.1	0.34	0.99	0.06	-0.5	0.53	-0.08	-0.16	0.44	0.75	0.04	0.02	0.99	-0.5	-0.11	-0.1	-0.48	0.14	-0.5
Non Current Assets Total	0.34	0.53	0.13	0.03	0.92	0.36	-0.1		0.09	-0.07	0.56	-0.01	0.53	0.86	0.35	0.52	0.49	0.58	0.79	-0.01	-0.01	0.88	0.74	0.02	-0.2	-0.72
Non Currrent Assets Other	0.34	0.06	-0.01	0.32	0.1	-0.31	0.34	0.09		0.34	-0.22	-0.12	0.19	0.05	0.04	0.19	0.32	0.02	0.04	0.33	-0.12	0.03	0.42	-0.11	-0.08	-0.26
Cash And Short Term Investments	0.91	0.24	0.23	0.93	0.1	-0.92	0.99	-0.07	0.34		0.1	-0.52	0.6	-0.04	-0.18	0.43	0.76	0.11	0.08	1.0	-0.52	-0.06	-0.09	-0.49	0.22	-0.53
Net Receivables	0.33	0.25	0.32	0.13	0.54	0.07	0.06	0.56	-0.22	0.1		-0.07	0.53	0.41	0.0	0.08	0.44	0.43	0.5	0.14	-0.06	0.42	0.39	-0.01	0.13	-0.48
Common Stock Total Equity	-0.5	-0.63	-0.4	-0.39	-0.33	0.4	-0.5	-0.01	-0.12	-0.52	-0.07		-0.59	-0.16	-0.09	-0.41	-0.64	-0.32	-0.33	-0.53	1.0	-0.15	0.38	0.94	-0.35	0.5
Common Stock Shares Outstanding	0.79	0.65	0.54	0.52	0.68	-0.33	0.53	0.53	0.19	0.6	0.53	-0.59		0.5	0.26	0.61	0.84	0.61	0.68	0.64	-0.58	0.5	0.22	-0.56	0.32	-0.82
Non Current Liabilities Total	0.31	0.48	0.46	-0.1	0.9	0.4	-0.08	0.86	0.05	-0.04	0.41	-0.16	0.5		0.22	0.45	0.41	0.85	0.92	0.01	-0.15	1.0	0.63	-0.07	0.16	-0.69
Inventory	0.0	0.62	-0.04	-0.08	0.32	0.22	-0.16	0.35	0.04	-0.18	0.0	-0.09	0.26	0.22		0.64	0.13	0.1	0.2	-0.13	-0.09	0.27	0.23	-0.09	-0.27	-0.21
Other Current Assets	0.64	0.76	0.05	0.51	0.6	-0.26	0.44	0.52	0.19	0.43	0.08	-0.41	0.61	0.45	0.64		0.7	0.29	0.45	0.48	-0.41	0.47	0.31	-0.39	-0.22	-0.71
Other Stockholder Equity	0.92	0.63	0.21	0.78	0.64	-0.56	0.75	0.49	0.32	0.76	0.44	-0.64	0.84	0.41	0.13	0.7		0.36	0.52	0.79	-0.64	0.4	0.24	-0.6	0.01	-0.92
Total Liab	0.34	0.42	0.85	-0.1	0.74	0.26	0.04	0.58	0.02	0.11	0.43	-0.32	0.61	0.85	0.1	0.29	0.36		0.91	0.14	-0.31	0.84	0.38	-0.26	0.64	-0.58
Property Plant And Equipment Gross	0.4	0.59	0.64	-0.01	0.93	0.29	0.02	0.79	0.04	0.08	0.5	-0.33	0.68	0.92	0.2	0.45	0.52	0.91		0.13	-0.32	0.91	0.47	-0.32	0.36	-0.77
Total Current Assets	0.94	0.29	0.24	0.94	0.16	-0.91	0.99	-0.01	0.33	1.0	0.14	-0.53	0.64	0.01	-0.13	0.48	0.79	0.14	0.13		-0.53	-0.01	-0.05	-0.5	0.2	-0.57
Common Stock	-0.5	-0.63	-0.39	-0.4	-0.33	0.41	-0.5	-0.01	-0.12	-0.52	-0.06	1.0	-0.58	-0.15	-0.09	-0.41	-0.64	-0.31	-0.32	-0.53		-0.15	0.38	0.94	-0.34	0.5
Short Long Term Debt Total	0.3	0.51	0.43	-0.11	0.91	0.42	-0.11	0.88	0.03	-0.06	0.42	-0.15	0.5	1.0	0.27	0.47	0.4	0.84	0.91	-0.01	-0.15		0.63	-0.07	0.13	-0.69
Accounts Payable	0.22	0.08	0.02	-0.01	0.55	0.28	-0.1	0.74	0.42	-0.09	0.39	0.38	0.22	0.63	0.23	0.31	0.24	0.38	0.47	-0.05	0.38	0.63		0.46	-0.26	-0.44
Intangible Assets	-0.46	-0.64	-0.36	-0.39	-0.31	0.4	-0.48	0.02	-0.11	-0.49	-0.01	0.94	-0.56	-0.07	-0.09	-0.39	-0.6	-0.26	-0.32	-0.5	0.94	-0.07	0.46		-0.35	0.46
Current Deferred Revenue	0.12	-0.02	0.93	-0.11	0.05	-0.05	0.14	-0.2	-0.08	0.22	0.13	-0.35	0.32	0.16	-0.27	-0.22	0.01	0.64	0.36	0.2	-0.34	0.13	-0.26	-0.35		-0.01
Retained Earnings	-0.79	-0.66	-0.29	-0.55	-0.85	0.24	-0.5	-0.72	-0.26	-0.53	-0.48	0.5	-0.82	-0.69	-0.21	-0.71	-0.92	-0.58	-0.77	-0.57	0.5	-0.69	-0.44	0.46	-0.01

Click cells to compare fundamentals

Cellectis Account Relationship Matchups

Cellectis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	467.5M	469.5M	382.1M	261.2M	334.3M	270.8M
Other Current Liab	12.2M	20.2M	14.6M	25.6M	12.1M	11.7M
Total Current Liabilities	62.6M	52.0M	49.3M	63.0M	155.1M	162.9M
Total Stockholder Equity	315.1M	275.6M	221.3M	118.0M	84.7M	80.5M
Property Plant And Equipment Net	69.3M	145.5M	148.3M	107.9M	92.7M	97.4M
Net Debt	(313.3M)	(156.9M)	(83.9M)	(14.8M)	(43.9M)	(46.0M)
Cash	360.9M	268.2M	186.1M	97.7M	136.7M	183.6M
Non Current Assets Total	75.9M	154.1M	156.6M	117.4M	101.3M	56.0M
Non Currrent Assets Other	102K	(1K)	5.5M	3K	1K	(950.0)
Cash And Short Term Investments	360.9M	268.2M	186.1M	97.7M	203.8M	187.9M
Net Receivables	12.1M	19.2M	31.1M	17.6M	23.1M	16.6M
Common Stock Total Equity	2.4M	2.8M	2.8M	2.8M	2.5M	2.4M
Common Stock Shares Outstanding	42.4M	42.5M	44.8M	45.5M	57.0M	33.4M
Liabilities And Stockholders Equity	467.5M	469.5M	382.1M	261.2M	334.3M	270.8M
Non Current Liabilities Total	49.4M	108.6M	96.3M	72.3M	94.4M	99.2M
Inventory	2.9M	1.6M	0.0	21.8M	1K	950.0
Other Current Assets	15.6M	26.3M	8.2M	28.5M	6.1M	9.4M
Other Stockholder Equity	843.5M	863.9M	934.7M	583.1M	522.8M	434.1M
Total Liab	112.0M	160.6M	145.6M	135.3M	249.6M	262.1M
Property Plant And Equipment Gross	69.3M	145.5M	148.3M	107.9M	168.2M	176.6M
Total Current Assets	391.5M	315.4M	225.4M	143.8M	233.0M	214.9M
Accumulated Other Comprehensive Income	(22.6M)	(4.1M)	(18.0M)	(28.6M)	(36.7M)	(38.5M)
Common Stock	2.8M	2.8M	2.9M	3.0M	4.4M	4.1M
Short Long Term Debt Total	47.6M	111.3M	102.2M	82.8M	92.9M	97.5M
Accounts Payable	29.3M	24.6M	23.8M	21.5M	19.1M	18.8M
Intangible Assets	1.1M	1.6M	1.9M	718K	671K	637.5K
Current Deferred Revenue	20.0M	452K	301K	59K	110.3M	115.8M
Retained Earnings	(508.5M)	(587.0M)	(698.3M)	(439.5M)	(405.8M)	(426.1M)
Short Term Debt	1.1M	6.7M	10.6M	12.8M	13.7M	14.3M
Other Assets	1.9M	5.5M	7.0M	6.5M	1K	950.0
Other Liab	2.9M	8.6M	6.0M	9.4M	10.8M	11.3M
Net Tangible Assets	314.0M	274.0M	219.4M	117.3M	134.8M	243.1M
Long Term Debt	46.5M	28.8M	18.8M	20.5M	28.4M	15.2M
Long Term Investments	5.5M	7.0M	6.5M	8.8M	7.9M	4.1M
Short Long Term Debt	333K	1.1M	2.2M	5.1M	5.2M	5.4M
Property Plant Equipment	69.3M	145.5M	148.3M	107.9M	124.1M	130.3M
Short Term Investments	20.4M	27.1M	499K	7.9M	67.1M	70.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC